By the Numbers | One nation, on ADHD meds?
March 27A recently released study by Medco Health Solutions, Inc. found that in America, the use of Attention Deficit Hyperactivity Disorder (ADHD) medications has skyrocketed over the past several years. The FDA is divided as to how to address concerns over ADHD medications: in February, an FDA advisory committee decided that ADHD medications' labeling should include "black box" warnings for "increased risk of sudden death and serious cardiovascular problems." But several days ago, the FDA's Pediatric Advisory Committee recommended that the risks to children in taking ADHD medications do not merit a "black box." In this installment of "By the Numbers," the Daily explores Americans' relationship with ADHD drugs.
